Dr. Ronald Seeliger is the CEO of Hemofarm Group. Dr. Ronald Seeliger has held the position of the CEO of Hemofarm since 2012. A year earlier, in 2011, he became a member of the STADA Group management. International experience in numerous companies worldwide, at significant managing positions, and primarily the results he has achieved, qualify him to lead the system of Hemofarm Group, which employs more than 2600 employees.
Dr. Ronald Seeliger graduated from the Technical University in Berlin, where he worked as teaching assistant, at the beginning of his career. He studied at the London School of Economics and IMD Business School in Lausanne, and earned doctor’s degree by defending the PhD thesis ‘Controlling Process in Media Campaigns’. He has been a part of management in major industrial systems in Europe, Australia and Asia. He has also been the Controlling Director in Formula 1.

Veran Matić is the President of the Management Board of B92 Fund and Council for Corporate Social Responsibility of the Chamber of Commerce and Industry of Serbia. He is the founder and president of the Board of Directors of B92, President of the Commission to Investigate Murders of Journalists of the Government of Serbia, Special Envoy of the President of the Republic of Serbia for solving the issue of missing persons with the Republic of Croatia, President of the Supervisory Board of the Budget Fund for Treatment of Children Abroad of the Ministry of Health and Co-President of the Philanthropy Council of the Government of Serbia. He has been active in the MB of the Youth Integration Centre and Serbian Philanthropy Forum. He has managed numerous philanthropic and socially responsible activities and campaigns: Battle for the Babies, maternity hospitals, voluntary blood donation, organ bequeathing and expansion of the bank of potential bone marrow donors, prevention of breast cancer with portable mammography machine, against family violence, construction of six safe houses, etc.
Socially responsible and philanthropic campaigns he has run have won major global recognitions, from the Bronze Lion at the Cannes Festival, to the awards of the European Festival of Creativity, CRESTA New York, awards of the European Parliament, numerous Virtus awards and also UEPS awards.

Prof. Dr. Vera Artiko is the Director of the Nuclear Medicine Centre at the Clinical Centre of Serbia, Head of Department for Specialist Studies in Nuclear Medicine, member of the Council of the Faculty of Medicine and Board for Biotechnical Studies of the University of Belgrade. She is a member of the Committee for Infections and Inflammations of the European Association of Nuclear Medicine (EANM) and a representative in the European School of Multimodality Imaging & Therapy (ESMIT), where she also lectures. She is a coordinator in the screening network of the Central European Exchange Program for University Studies (CEEPUS). She is a national representative in the Forum for Medical Applications of the European Organization for Nuclear Research (CERN). She manages and participates in many projects of the International Atomic Energy Agency (IAEA), Erasmus Plus and Ministry of Education, Science and Technological Development of the Republic of Serbia. She is an author in numerous publications, winner of several awards, member of editorial boards in several foreign magazines, lecturer and organizer of numerous local and foreign professional meetings.

Nikola Ivica was born in Pančevo in 1989. He finished the primary school ’Stevica Jovanović’, musical school ’Jovan Bandur’, and three grades of the high school ’Uroš Predić’, and he attended the last year of secondary school in ’Mascoma Valley’ regional school of the federal state of New Hampshire, the USA. While he was in high school, he was a student at the Research Centre Petnica in the field of biology and played volleyball for the volleyball club ’Dinamo’ from Pančevo, and also for the cadet representation of Serbia and Montenegro, later Serbia. He graduated in chemistry and physical biology at Harvard University with Latin honours. He defended the diploma thesis with the highest grade before the committee comprised of Dr. Jack Szostak (Nobel Laureate in 2009) and Dr. Richard Losick. Nikola is Post-doctoral associate MIT Koch Institute for Integrative Cancer Research.